Jillian Gauld Institute for Disease Modeling April 20, 2017

Slides:



Advertisements
Similar presentations
Infectious Disease Epidemiology EPIET Introductory Course, 2006 Lazareto, Menorca Prepared by: Mike Catchpole, Johan Giesecke, John Edmunds, Bernadette.
Advertisements

Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
Dengue Transfusion Risk Model Lyle R. Petersen, MD, MPH Brad Biggerstaff, PhD Division of Vector-Borne Diseases Centers for Disease Control and Prevention.
Mathematical models for interventions on drug resistance Hsien-Ho Lin.
Insights from economic- epidemiology Ramanan Laxminarayan Resources for the Future, Washington DC.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Incidence and Prevalence
How does mass immunisation affect disease incidence? Niels G Becker (with help from Peter Caley ) National Centre for Epidemiology and Population Health.
Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)
Methods to Study and Control Diseases in Wild Populations Steve Bellan, MPH Department of Environmental Sci, Pol & Mgmt University of California at Berkeley.
Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.
Epidemiology.
Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.
Infectious disease, heterogeneous populations and public healthcare: the role of simple models SIAM CSE 2009 K.A. Jane White Centre for Mathematical Biology.
Genetic-Environmental Interaction: Implications for Osteoporosis Prevention Strategies.
Unit 12-13: Infectious Disease Epidemiology. Unit Learning Objectives: 1.Understand primary definitions used in infectious disease epidemiology.
Nina H. Fefferman, Ph.D. Rutgers Univ. Balancing Workforce Productivity Against Disease Risks for Environmental and Infectious.
Modelling infectious diseases Jean-François Boivin 25 October
Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.
Various topics Petter Mostad Overview Epidemiology Study types / data types Econometrics Time series data More about sampling –Estimation.
New vaccines mean new strategies: A theoretical exploration of the impact of HPV/HSV vaccines. Geoff Garnett Department of Infectious Disease Epidemiology,
Risk Assessments: Models for Estimating the Risk of Transmitting TSE by Human Tissue Intended for Transplantation Rolf E. Taffs, Ph.D. Center for Biologics.
Showcase /06/2005 Towards Computational Epidemiology Using Stochastic Cellular Automata in Modeling Spread of Diseases Sangeeta Venkatachalam, Armin.
A Stochastic Model of Paratuberculosis Infection In Scottish Dairy Cattle I.J.McKendrick 1, J.C.Wood 1, M.R.Hutchings 2, A.Greig 2 1. Biomathematics &
Risk Assessment* and Zoonotic Implications Yvonne Nadler DVM MPH April 6, 2011 * THE FUN STUFF.
CDC's Model for West Africa Ebola Outbreak Summarized by Li Wang, 11/14.
Using Models to Assess Microbial Risk: A Case Study CAMRA August 10 th, 2006.
1 Preparedness for an Emerging Infection Niels G Becker National Centre for Epidemiology and Population Health Australian National University This presentation.
1 Immunisation with a Partially Effective Vaccine Niels G Becker National Centre for Epidemiology and Population Health Australian National University.
Mathematical modelling of male circumcision in sub-Saharan Africa predicts significant reduction in HIV prevalence Greg Londish 1, John Murray 1,2 1 School.
Exposure Prediction and Measurement Error in Air Pollution and Health Studies Lianne Sheppard Adam A. Szpiro, Sun-Young Kim University of Washington CMAS.
04/19/ Projected effectiveness of mass HIV vaccination with multi-dose regimens to be tested in South Africa Peter Gilbert Dobromir Dimitrov Christian.
Evaluation of Microbiological Risks Associated with Direct Potable Reuse (DPR) Water Microbiology Conference 2016 University of North Carolina May 2016.
Mumps Resurgence at a Large University Campus Town Awais Vaid, MBBS, MPH Epidemiologist and Director of Planning Champaign-Urbana Public Health District.
Instructional Objectives:
Stochasticity vs. Noise in Malaria Studies & Simulation
Sangeeta Venkatachalam, Armin R. Mikler
LIABILITY PORTFOLIO MANAGEMENT Diversification of Longevity and Mortality Risk Stuart Silverman, FSA, MAAA, CERA Longevity 12 September 29-30, 2016.
WASH and Cholera Preparedness to Response-
The Changing Epidemiology of Acute Hepatitis A in Texas
MARAM International Stock Assessment Workshop
Models.
Vaccine Efficacy, Effectiveness and Impact
The Role of Supplementary Immunization Activity Scheduling on Measles Incidence in Nigeria Kurt Frey April 20, 2017 IDM Disease Modeling Symposium Measles.
A Primer on Health Economics and Cost-Effectiveness
When Security Games Go Green
Modelling infectious diseases
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
Déirdre Hollingsworth University of Warwick
The Emma Barnsley Foundation
Testing Efficiency Indicators
Travel Patterns and Disease Transmission
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
Quantitative Risk Assessment
TYPHOID CASES IN SOUTH AFRICA AND GAUTENG PROVINCE
Implementation Challenges
Seasonality of viral infections: mechanisms and unknowns
Analysis of missing responses to the sexual experience question in evaluation of an adolescent HIV risk reduction intervention Yu-li Hsieh, Barbara L.
To vannamei or not to vannamei …
Peter Godfrey-Faussett for Charlotte Watts
Epidemiological Measurements of health
Susceptible, Infected, Recovered: the SIR Model of an Epidemic
Maintaining Elimination in an Environment of Persistent Importation
Applied Simulation Modeling for Interrupting Malaria Transmission on Bioko Island Daniel T. Citron April 15, 2019 Worked in close collaboration with the.
Measures of Disease Occurrence
Epidemiology of hepatitis A in Ireland
Introduction to OpenMalaria
Overview of HIV Prevention Cascade Discussions. Geoff Garnett
Assessing similarity of curves: An application in assessing similarity between pediatric and adult exposure-response curves July 31, 2019 Yodit Seifu,
Presentation transcript:

Jillian Gauld Institute for Disease Modeling April 20, 2017 Typhoid Fever in Santiago, Chile: Modern Insights Where Historical Data Meet Mathematical Modeling Jillian Gauld Institute for Disease Modeling April 20, 2017

Outline Typhoid and Santiago overview Modeling approach Lessons learned: Age distribution and immunity/exposure Chronic carriage and short cycle transmission Vaccine impacts Take-aways: site specific and new locations

Typhoid as a deadly disease Wong et al. Nature Genetics

Typhoid modeling initiative Motivating questions: Is local elimination feasible with current and upcoming tools? What do we need to know in order to make informed decisions around control and elimination?

Typhoid modeling initiative Water supply in Kathmandu, Nepal Challenging features: Transmission route varied and unknown in many locations Irrigation practices in Santiago, Chile

Typhoid modeling initiative Challenging features: Transmission route varied and unknown in many locations Mechanisms of persistence unclear

Typhoid modeling initiative Challenging features: Transmission route varied and unknown in many locations Mechanisms of persistence unclear

Santiago, Chile Very low level typhoid incidence in modern day In the 1970-1980s: high endemic transmission despite >90% sewage and drinking water coverage Decline in 1980s coincident with Ty21a vaccine trial 1991 ban of wastewater irrigation: sharp decline in cases

Why model in Santiago? Three different transmission periods in a single population/ demographic set Data that is not commonly available: Age distribution, seasonality, transmission route, carrier prevalence, low endemic transmission Allows us to explore underlying mechanisms for observed dynamics and understand areas of uncertainty

Modeling approach Individual-based model: Allows for individual level variation in parameters including immunity, shedding duration, and carrier probabilities

Modeling approach Key components: Infections can be either acute or subclinical Permanent chronic carrier state Protection-per-infection parameter

Modeling transmission routes Distinct transmission routes in model: Long cycle: Homogenous mixing, dose-response dynamics, decay in water/ environment Short cycle: Non-seasonal, modeled as direct transmission contaminated food

Model fitting process Optimization to maximize likelihoods informing model fit to age distribution, incidence, carrier prevalence, seasonality Point estimates for unknown parameters Proportion of typhoid incidence in age bins Proportion of typhoid incidence in age bins -- Simulation X Data

Take-aways from model fitting Immunity and exposure trade-off to create adult age distribution of typhoid Population immunity: None Low High

Take-aways from model fitting Immunity and exposure trade-off to create adult age distribution of typhoid Best fit model >95% protection after initial infection Contrasts with challenge models Boosting from environment in endemic regions? Dupont, 1971: Challenge study with re-exposure within 12 months of initial infection

Take-aways from model fitting Immunity and exposure trade-off to create adult age distribution of typhoid Best fit model >95% protection after initial infection Contrasts with challenge models Boosting from environment in endemic regions? We are likely catching a small fraction of total cases: <10% total cases (clinical/subclinical) reported in model

Take-aways from model fitting Exposure likely drives childhood age distribution: Increases in incidence timed with entry ages into preschool, elementary school system  potential exposure to new foods

Take-aways from model fitting Exposure likely drives childhood age distribution: Increases in incidence timed with entry ages into preschool, elementary school system  potential exposure to new foods Site-specific, flexible mechanisms needed to capture variation across locations

We can estimate the probability of becoming a chronic carrier from infection Age/gender distribution determined by age distribution of gallstones Point estimates of probability of becoming a chronic carrier in range of estimates from Ames, 1943 Best-fit model estimates, cases resulting in carriers(%) Add age group Age Male Female 10-19 1.4 20-29 0.7 3.3 30-39 2.0 6.0 40-49 2.5 7.2 50-59 3.0 8.4 60-69 3.7 9.7 70-79 6.5 80-90 6 7.8 Ames, 1943

Low-season persistence and the importance of chronic carriers Highly seasonal locations: trade-offs between long and short cycle dominated scenarios What sustains typhoid in short cycle dominated scenarios? Typhoid in Santiago, Chile Typhoid in Blantyre, Malawi Kathmandu, Nepal Data shared from Mike Levine Karkey et al., 2015 Feasey, 2015

What sustains typhoid during the low season? Three possible contributors: Chronic carriers

What sustains typhoid during the low season? Three possible contributors: Chronic carriers Sustained long-tail shedding Ames, 1943

What sustains typhoid during the low season? Survival of S. Typhi on vegetables, Tetsumoto 1934 Three possible contributors: Chronic carriers Sustained long-tail shedding Environmental persistence Decline of culturable cells, total cells in unfiltered groundwater. Cho 1999

Low-season persistence and the importance of chronic carriers Chronic carriers are not necessary to capture transmission dynamics in endemic Santiago Model dynamics, no chronic carriers

Estimating the impact of chronic carriers Complete cutoff of long cycle transmission in 1991 allows us to estimate short cycle transmission and chronic carrier infectiousness Vaccination campaign of Ty21a Environmental intervention

Estimating the impact of chronic carriers Sustained transmission after 1991 can’t be explained by short cycle transmission without chronic carriers Chronic carriers are ~18% as infectious as acute cases in this setting No carrier infectiousness Fitted carrier infectiousness

Estimating impact of chronic carriers Public health implications: even with cessation of long cycle transmission, chronic carriers can sustain transmission through the short cycle in this setting Implications for vulnerable systems: continued impact of intervention, or carrier case finding necessary for elimination scenarios

Estimating vaccine impact: what contributed to the decline in cases?

Fitting changes in incidence Original assumption: sharp increase in cases in 1983 not necessary to capture decline, fit to mean over years prior to vaccination Incidence of typhoid in Santiago, Chile Baseline • Santiago Data

Fitting changes in incidence Original assumption: underestimates decline in cases seen Incidence of typhoid in Santiago, Chile Baseline Vaccine • Santiago Data

Fitting changes in incidence • Santiago Data Unemployment rate (%) GDP change (%) Food inspection counts Data courtesy Catterina Ferreccio

We still don’t capture the decrease in incidence Incidence of typhoid in Santiago, Chile Vaccine duration of efficacy may be longer than evaluated 7 year maximum follow-up, 3 years or less for less efficacious formulations Debate regarding environmental impact No data informing any quantitative changes in exposure through the environment Incidence per 100,000 62% efficacy, 7 year duration assumed for all vaccines for at least 3 doses, short interval = 216,691 143,451 received non-long term evaluated dosage, used minimum-evaluated years and efficacy % PLOT LOOKING MUCH CLOSER Vaccine Baseline • Santiago Data

We still don’t capture the decrease in incidence Hint: age distribution of typhoid during/ after the vaccination period Proportion of total incidence 62% efficacy, 7 year duration assumed for all vaccines for at least 3 doses, short interval = 216,691 143,451 received non-long term evaluated dosage, used minimum-evaluated years and efficacy %

Age distribution differs by intervention type Decline due to environmental intervention Decline due to vaccine Model fitted to decline in incidence between 1983 and 1991: 100% attributed to environment vs. vaccine Distinct shifts in age distribution when decline is due to vaccine Age distribution conserved across decline for environmental change Proportion of total incidence Age bin

Age distribution and vaccine duration Best fit model results for age distribution over time Fitting vaccine duration to age distribution indicates duration may be longer than originally evaluated Indication of herd effects from typhoid vaccine in Santiago Application to present day - Simulation • Santiago Data

Take-aways from modeling typhoid in Santiago Age specific exposure and immunity are important to capture the age distribution of typhoid India Blantyre, Malawi Fiji Sinha 1999 Incidence per 100,000 Age (years) John et al. 2016 Feasey et al. 2015 Thompson et al. 2014

Take-aways from modeling typhoid in Santiago Age specific exposure and immunity are important in explaining the age distribution of typhoid Chronic carriers played a large role in Santiago persistence after long cycle cutoff

Take-aways from modeling typhoid in Santiago Age specific exposure and immunity are important in explaining the age distribution of typhoid Chronic carriers played a large role in Santiago persistence after long cycle cutoff Utilize contextual approaches for vaccine impact estimation

Take-aways from modeling typhoid in Santiago Age specific exposure and immunity are important in explaining the age distribution of typhoid Chronic carriers played a large role in Santiago persistence after long cycle cutoff Utilize contextual approaches for vaccine impact estimation Parameter uncertainty: how do assumptions change across unknowns?

Multiple fits to Santiago data are possible within parameter uncertainty Daily exposure rate: 0.5 Approximately 50% of population exposed daily Daily exposure rate: 0.005 Approximately 0.5% of population exposed daily Seasonality Seasonality Source: QMRA wiki Age Distribution Age Distribution -- Simulation X Data

Multiple fits to Santiago data are possible within parameter uncertainty Daily exposure rate: 0.5 Approximately 50% of population exposed daily Daily exposure rate: 0.005 Approximately 0.5% of population exposed daily Seasonality Seasonality Source: QMRA wiki One slide to totally hide it. Approximately 0.5% exposed daily Incubation period Disease outcomes Potentially ----- Meeting Notes (5/18/16 17:47) ----- make sure to say high exposure low dose low exposure high dose Age Distribution Age Distribution -- Simulation X Data

Thanks! jgauld@intven.com Hao Hu, Dennis Chao & Epidemiology Team Thank you to Mike Levine, University of Maryland, for data sharing and collaboration